Market Overview:
The global tablet and capsule budesonide market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of respiratory diseases, increasing awareness about the benefits of budesonide therapy, and growing demand for generic drugs. Based on type, the global tablet and capsule budesonide market is segmented into tablets and capsules. The capsules segment is expected to register a higher CAGR during the forecast period as compared to tablets due to their high efficacy in treating respiratory diseases. Based on application, the global tablet and capsule budesonide market is segmented into respiratory disease treatment, nose disease treatment, inflammatory bowel disease treatment, and other applications. The respiratory disease treatment segment accounted for majority share of the global tablet and capsule budesonide market in 2017 owing to high prevalence of respiratory diseases across globe.
Product Definition:
A tablet is a solid dosage form of medication that is swallowed whole. A capsule is a gelatinous container filled with medication, which may be powdered or in solution. It can be opened and emptied into food if necessary, or dissolved in water before swallowing. Both tablets and capsules are designed to release their contents slowly as the drug passes through the gastrointestinal tract.
Tablet:
Budesonide is a type of drug that belongs to the group of drugs called bronchodilators. It works by opening airways and reducing the inflammation and swelling in the lung. Budesonide is used for treating symptoms of asthma as well as preventing them from occurring in some people who are susceptible to asthma attacks.
Capsule:
Capsule is a gelatin-based shell that contains drug and excipients. It is used to protect active ingredients from light, moisture, and temperature. The two types of capsules include soft gelatine capsules (equivalent to hard gelatin capsule) and dry powder capsules (equivalent to film-coated tablets).
Application Insights:
On the basis of application, the global tablet and capsule budesonide market is segmented into respiratory disease treatment, allergic rhinitis treatment, other diseases treatment, and nose disease treatment. Respiratory diseases treated with budesonide tablets or capsules include asthma as well as bronchospasm. The others segment includes inflammatory bowel disease (IBD) such as Crohn¢â‚¬â„¢s disease and ulcerative colitis. Capsule form of budesonide is approved by FDA for use in treating IBD under investigation phase 2/3 studies; however, it has not been approved for this indication yet.
The other category containing products includes psoriasis vulgaris.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its dominance. In addition, a strong distribution network and high patient awareness levels coupled with relatively higher healthcare expenditure levels are also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast years owing to rising disposable income levels and improving economic conditions in emerging countries such as India & China & South Korea among others which has led to an increase in demand for various pharmaceutical products including tablets and capsules among patients suffering from respiratory diseases such as asthma or COPD etc. Furthermore, growing medical tourism industry due to lower treatment costs is also expected positively impact regional growth rate over next few years.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for budesonide tablets and capsules in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options. This is likely to boost the demand for budesonide tablets and capsules in the near future.
- Rising number of product approvals: The number of product approvals for budesonide tablets and capsules has been rising in recent years, owing to their efficacy in treating respiratory diseases. This is likely to fuel market growth over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tablet and Capsule Budesonide Market Research Report
By Type
Tablet, Capsule
By Application
Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other
By Companies
AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, AstraZeneca, Shanghai Sine Promod
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Tablet and Capsule Budesonide Market Report Segments:
The global Tablet and Capsule Budesonide market is segmented on the basis of:
Types
Tablet, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- AstraZeneca
- Shanghai Sine Promod
Highlights of The Tablet and Capsule Budesonide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- By Application:
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tablet and Capsule Budesonide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Budesonide is a medication used to treat asthma. It is a type of corticosteroid and works by reducing inflammation in the airways.
Some of the major companies in the tablet and capsule budesonide market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, AstraZeneca, Shanghai Sine Promod.
The tablet and capsule budesonide market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tablet and Capsule Budesonide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tablet and Capsule Budesonide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tablet and Capsule Budesonide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tablet and Capsule Budesonide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tablet and Capsule Budesonide Market Size & Forecast, 2018-2028
4.5.1 Tablet and Capsule Budesonide Market Size and Y-o-Y Growth
4.5.2 Tablet and Capsule Budesonide Market Absolute $ Opportunity
Chapter 5 Global Tablet and Capsule Budesonide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tablet and Capsule Budesonide Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tablet and Capsule Budesonide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tablet and Capsule Budesonide Market Size Forecast by Applications
6.2.1 Respiratory Disease Treatment
6.2.2 Nose Disease Treatment
6.2.3 Inflammatory Bowel Disease Treatment
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tablet and Capsule Budesonide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tablet and Capsule Budesonide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tablet and Capsule Budesonide Analysis and Forecast
9.1 Introduction
9.2 North America Tablet and Capsule Budesonide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tablet and Capsule Budesonide Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tablet and Capsule Budesonide Market Size Forecast by Applications
9.10.1 Respiratory Disease Treatment
9.10.2 Nose Disease Treatment
9.10.3 Inflammatory Bowel Disease Treatment
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tablet and Capsule Budesonide Analysis and Forecast
10.1 Introduction
10.2 Europe Tablet and Capsule Budesonide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tablet and Capsule Budesonide Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tablet and Capsule Budesonide Market Size Forecast by Applications
10.10.1 Respiratory Disease Treatment
10.10.2 Nose Disease Treatment
10.10.3 Inflammatory Bowel Disease Treatment
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tablet and Capsule Budesonide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tablet and Capsule Budesonide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tablet and Capsule Budesonide Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tablet and Capsule Budesonide Market Size Forecast by Applications
11.10.1 Respiratory Disease Treatment
11.10.2 Nose Disease Treatment
11.10.3 Inflammatory Bowel Disease Treatment
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tablet and Capsule Budesonide Analysis and Forecast
12.1 Introduction
12.2 Latin America Tablet and Capsule Budesonide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tablet and Capsule Budesonide Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tablet and Capsule Budesonide Market Size Forecast by Applications
12.10.1 Respiratory Disease Treatment
12.10.2 Nose Disease Treatment
12.10.3 Inflammatory Bowel Disease Treatment
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tablet and Capsule Budesonide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tablet and Capsule Budesonide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tablet and Capsule Budesonide Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tablet and Capsule Budesonide Market Size Forecast by Applications
13.10.1 Respiratory Disease Treatment
13.10.2 Nose Disease Treatment
13.10.3 Inflammatory Bowel Disease Treatment
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tablet and Capsule Budesonide Market: Competitive Dashboard
14.2 Global Tablet and Capsule Budesonide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Teva
14.3.3 Mylan
14.3.4 Sandoz
14.3.5 Cosmo Pharmaceuticals
14.3.6 Salix
14.3.7 Chiesi Farmaceutici
14.3.8 Orion Corporation
14.3.9 Cipla
14.3.10 Synmosa Biopharma
14.3.11 AstraZeneca
14.3.12 Shanghai Sine Promod
